Skip to main content
. 2023 Feb 20;9(4):337–342. doi: 10.1093/ehjcvp/pvad009

Figure 1.

Figure 1

Sex differences in LDL-C reduction induced by PCSK9 monoclonal antibodies in a real-life setting. Forest plot of the difference in LDL-C reduction between men and women. LDL-C reduction was evaluated with a mean difference expressed in mg/dL. The diamond represents the estimated overall effect, while the squares represent each study with 95% CI. LDL-C, low-density lipoprotein cholesterol; RCT, randomized clinical trial; CI, confidence interval.